Day 1 Dinner Symposium
|Title||The value of pneumococcal vaccination in adults with co-morbid conditions|
|Details||Date: November 11, 2021
Time: 19:15 – 20:15 (SGT)
|Synopsis||Pneumonia is an important cause of morbidity and mortality worldwide, and imposes a heavy economic burden on health-care systems. Fortunately, pneumococcal disease is vaccine preventable and so pneumococcal vaccination has been recommended in national immunization schedules across many countries. This talk will focus on the burden of adult pneumococcal disease and how co-morbid conditions are associated with this burden. In addition, current and future pneumococcal vaccine recommendations for adults will be discussed.|
|Objectives||Understand the burden of pneumococcal disease and the value of vaccination to prevent this disease in adults|
|Schedule||19:30 – 20:10 (40 mins) Presentation
20:10 – 20:30 (20 mins) Q&A
A/Prof Helen Oh, Singapore
Dr Helen Oh is a senior consultant with the Department of Infectious Diseases at Changi General Hospital (CGH). She received her medical degree from the National University of Singapore. She then went on to receive training in adult Infectious Disease from University of British Columbia, Canada, as well as in molecular diagnostics from the University of Alabama, Birmingham, USA.Dr Oh is a member of the Technical Advisory Group (TAG) on immunization and vaccine preventable diseases, Western Pacific Regional Office, World Health Organisation since 2011. Her research interests include dengue immunology, nosocomial infections, travel vaccines as well as environmental decontamination.
Professor Charles Feldman, South Africa
Charles Feldman is Distinguished Professor of Pulmonology at the University of the Witwatersrand, Johannesburg, South Africa. He is a Fellow of the College of Physicians (South Africa) and the Royal College of Physicians (United Kingdom), and is registered as a subspecialist in Pulmonology.His research interest is translational and in the field of community-acquired pneumonia, particularly pneumococcal pneumonia and in the setting of HIV infection. He also has a keen interest in adult pneumococcal vaccination. He has authored over 350 publications and is a National Research Foundation (South Africa) A-rated scientist.